Regen Biopharma Inc (PK) (RGBP) Quote

Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate

SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate™, the company’s innovative stem cell-derived therapy, which has already received FDA clearance. While the initial focus is on treating aplastic anemia, Regen BioPharma is evaluating expanded applications for this groundbreaking therapy in a market poised for significant growth.

HemaXellerate™ is designed to stimulate bone marrow regeneration following injury caused by autoimmune conditions, chemotherapy, or radiation. While the company’s initial target is aplastic anemia—a rare orphan indication—it sees substantial potential in treating chemotherapy-induced bone marrow suppression, a market valued at over $1 billion annually. This is evidenced by the success of products like Neulasta, which addresses similar unmet needs.

“Aplastic anemia patients without access to bone marrow transplantation face limited options,” said Dr. David Koos, Chairman and CEO of Regen BioPharma. “With FDA clearance to begin clinical trials, HemaXellerate™ has the potential to redefine the treatment landscape—not just for aplastic anemia but for a wide range of hematological disorders. This is a pivotal moment for our company as we work to deliver life-changing therapies to patients worldwide.”

To ensure the trial’s success, Regen BioPharma has partnered with a clinical research organization (CRO) known for its expertise in conducting complex trials. Once initiated, the study is expected to reach completion within 12 to 14 months.

Key Highlights for Investors:

Opportunity: Aplastic anemia is a rare disease with high unmet medical need, offering the potential for accelerated regulatory pathways and market exclusivity.

Massive Market Potential: Expansion into chemotherapy-induced bone marrow suppression could unlock a multi-billion-dollar market.

Strategic Execution: Collaboration with a leading CRO ensures focused execution and timeline adherence.

About Regen BioPharma, Inc.

Regen BioPharma, Inc. is a publicly traded biotechnology company (PINK: RGBP) and (PINK: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.

https://finance.yahoo.com/news/regen-biopharma-inc-expands-vision-210500940.html

https://www.otcmarkets.com/stock/RGBP/news/story?e&id=3052310

If the cancer part is accurate, this is where I potentially speaking see this shell to be finally acquired. Hopefully he finally let us go

I couldn't agree with you more on this.

where are you hearing this? Remember, he resigned as CEO of REGEN with no reason given and no one to take over for about a year before he came back. It was at that time the pump of the decade happened with the stock. I wouldn't be surprised if he did have some sort of health issues. He hasn't looked healthy.

Rumor has it that Kooscous has serious cancer and has gone to Tel Aviv for treatment. Incredibly, he used the medical field of cancer to swindle shareholders and karmic law punished him with a backlash.....
Boomerang !!!

Good luck with FINRA looking into it

That's FINRA's department.

Except in extremely rare cases, R/S are a scam. The SEC needs to make the rules more strict. Why is a company like Regen BioPharma with unaudited financials allowed to RS? There's no reason for it except to screw over shareholders.

I've never witnessed a reverse/split help matters for any stock long-term.

I just caught up with Konman Koos very informative vids from the emerging turd conferences he shows his fat face at. It is absolutely hilarious that they are trying to find funding for a P1 trial for HemaX. Funny how he did a 180. He abandoned HemaX long ago to push his other crap and those programs didn't go anywhere, he and Loser Lander had to go back to HemaX. It will be interesting to see if he can find a sucker to give him money to fund a P1 trial for HemaX. I don't think he's going to be lucky in finding another mark. Anyone doing their DD into Koos would realize he's a scam artist. Talking about scam artists, where is 29IQ?

Who would've thought a reverse split would turn into a complete failure in the OTC. Going back to pennies.

It means you lost a bunch more money messing around with another SCAM.

yes i see.!! thanks! makes sense. i have rgbp and twice as much rgbpp
RGBPP O/S 10M! https://www.otcmarkets.com/stock/RGBPP/security
RGBP O/S 4.5M https://www.otcmarkets.com/stock/RGBP/security

You should still have RGBP and if you were on record of holding any shares in RGBP or RGBPP before the close of the record date, then you were allotted a dividend share count. So let’s say you had 100 shares of RGBP before the market close on the record date, you would have received 200 shares of RGBPP as a dividend.

RGBP WENT AWAY IN MY ACCOUNT AND NOW I HAVE RGBPP .. anyone know what this means? i know it means preferred but did the company decide to do away with rgbp??

Yes I’m a newbie with only decades on IHub (Check the posting history sonny boy).
I love your wide- eyed wonderment that you seem to have discovered a “scam” on the OTC. I’m impressed.
You must have been equally amazed that the sun came up this morning, LOL
Tooooooo funny….

You sound like a newbie, you have not idea what you’re talking about. This company is 100% scam and it is manipulated in such way to lock in every investor that trades heavy. If you are talking about penny seekers that invest $50-$100 only, then. I believe you will find liquidity to get out but good luck with making profits with fees.

Actual traders bought at sub .30 a little back and are doing their flip thing while the pretenders resort to playground name-calling because that’s all they’ve got.
Wow- how easy the simple are satisfied.
I think I’d rather have the cash…

LMAO

The scam is now 43 cents fool. Quit trying to con people, it's pathetic.

That post aged really, REALLY well.
So I guess your red letter prediction for tomorrow is another 60% gain?
Cooooool

LMAO

Hot summer ?
Yes ! but downwards.
Money back ?
Not with the conman liar thief Kouscous...

What's the plan, Koos? Anyone? Hot summer in front of us?
The big question is how do we get our money back.
I think Rgbpp and Rgbp will come under same umbrella as one class of shares soon. After a share dividend shareholders should not be against such a decision.
Market capitalisation of Rgbp was only a million or so. If there is any meat in the Regen's science the price of the company should be attractive even to individuals if not companies.

This is just about cooked.

My divi showed up today

Rgbp Short Sale Volume (Off-Exchange Provided by FINRA) over 67% Friday
https://fintel.io/ss/us/rgbp
Scroll down to Short Sale Volume (Off-Exchange Provided by FINRA)

Oh we know.

Keep scamming. It's what Koos Koos does for a sordid living.

Nobody knows what Koos is planning after this unexpected gift to shareholders!!! Hmm. Big tax break for REGEN Biopharma

Cause still down over 95%

My guess is that your broker is in the process of paying out your dividend. My account on the other hand shows nothing, no change at all.

Does anyone know why our rgbp shares now show a number 75886M300 instead of the symbol rgbp and value at Schwab.

75886M300
REGEN BIOPHARMA INC
$226.63 3 336
$0.67453
N/A
N/A
-$3.63
N/A

I wanted to add, “Speculations Only”… Playing The Devil’s advocate in here, could it be possible an adquisición or buyout into REGEN Biopharma is on the works and these shares structure must be consolidated for the simplicity of such transaction? Getting Rgbpp out of the way, by bringing them into the common side, makes sense a buyout could be in the works

Anyone care to answer or add into such possibility?

Does anyone know the reason of this Dividend? I mean, WOW, thank you Koos, WOW, this is awesome!!! I didn’t see this coming, HE IS DA MAN!!! Anyways, can someone explain what’s the catch behind all this greatness? Koos doesn’t give nothing for free or for the faint of heart. Something is not right. It feels like he didn’t have space for dilution and this is a legal way to dilute the rgbpp shares, now that they are common

In a nutshell, you meant to say: This is Acid, a lemon. Keep it simple

Once my accounts are credited, I'll have 4136 RGBPP shares between both accounts.

Must be E*trade I have 2 other brokers and I have received mine. All the best!

Yep mine showed up also I only bought 335 shares July 1st I had a bid in for 1,000 shares but only got 335 filled the others did not fill.
I had 1 share left in my account from long ago. Now I have 672 free preferred shares.
I try to tell folks the record date does not matter with a special dividend only the ex- date. Now who ever sold to me on July 1st will not get the dividend.
RGBPP
REGEN BIOPHARMA, I 0%PFD SUBJ TO XTRO REDEMPTION
$391.98 3 672
$0.58333
+$257.58
+$0.38331
+$391.98

07/01/2024 Buy
Trade Details RGBP
REGEN BIOPHARMA INC
335
$0.6666 $6.95 -$230.26

Well, I haven't received mine yet and I've been holding since 2021, it could be because all of me shares are in 2 of my E*TRADE's accounts.

OK- all you bashers can now finally STFU! I received my RGBPP dividends shares in my brokerage account! 🐂🎤⚖️👏😝

This was copied from stocktwits.

$RGBP
RGBP
Regen Biopharma Inc


Good morning! I spoke with both my Fidelity and Schwab brokerage accounts again this morning to verify that they can now see that the preferred share dividend is pending with today being the pay date and Friday the 5th being the effective ex-dividend date according to FINRA, and they both acknowledged that they are seeing the dividend on their end now and that I qualify for the record date, and I should see the RGBPP shares delivered into my accounts by Friday. Have a great day everyone!

.75 was the high today. I sold all but 1 share when KOO KOO KOO,s did the Crazy R/S.
I bought a little today for the first time since the R/S just to see if I would get the dividend.
What a lot of people dont know is usually if you sell your stock before one business day after the ex- date with a special dividend you lose the dividend to the buyer.
Sometimes a company pays a dividend in the form of stock rather than cash. The stock dividend may be additional shares in the company or in a subsidiary being spun off. The procedures for stock dividends may be different from cash dividends. The ex-dividend date is set the first business day after the stock dividend is paid (and is also after the record date).

If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. Your sale includes an obligation to deliver any shares acquired as a result of the dividend to the buyer of your shares, since the seller will receive an I.O.U. or "due bill" from his or her broker for the additional shares. Thus, it is important to remember that the day you can sell your shares without being obligated to deliver the additional shares is not the first business day after the record date, but usually is the first business day after the stock dividend is paid.
https://www.investor.gov/introduction-investing/investing-basics/glossary/ex-dividend-dates-when-are-you-entitled-stock-and

RGBPP is up 0.25 today @ $1.75

So, does anyone believe there will be a 1RGBP for 2RGBPP dividend paid out this week? and if there is a dividend, will RGBPP go up or down? inquiring minds want to know. I read that this was to take place around July 01st.
TIA

It's been a while since this last popped.

Item 5.03 Amendments to Articles of Incorporation

On May 20, 2024 Regen Biopharma, Inc. amended its Certificate of Incorporation adding the following Article 8 which is and reads as follows:

Shares of one class or series of stock may be issued as a share dividend in respect of another class or series.

Item 8.01 Other Events.

On May 21 , 2024 the Board of Directors of Regen Biopharma, Inc.(“Regen”) declared a dividend to all shareholders of record as of June 20,2024 (“Record Date”) to be paid to shareholders on or about July 1, 2024 such dividend to be payable in shares of the Regen’s authorized but unissued Series A Preferred Stock and to consist of two share of Series A Preferred Stock for every one share of Regen Biopharma, Inc. Common Stock owned as of the Record Date, every one share of Regen Biopharma, Inc. Series A Preferred Stock owned as of the Record Date, every one share of Series AA Preferred Stock owned as of the Record Date, every one share of Series M Preferred Stock owned as of the Record Date and every one share of Series NC Preferred Stock owned as of the Record Date

Item 9.01 Financial Statements and Exhibits

Red posts are a sad cry to “please put me on the Iggy bus cause nobody reads red”
Soooooo long…..

SidVicious

Re: Ultraz2 post# 31672

Sunday, 12/03/2017 3:09:18 PM

The CEO David Koos has never shown any success at running anything. He's run all of his companies into the ground. It's pretty much a scam for him to earn a paycheck and his trips to Tijuana to do things that aren't legal in the USA.

Koos is a snake oil salesman.

I keep asking what successes Koos has had in making money for his stockholders or running a company or bringing a druge to market. No one will answer because they all know the answer. ZERO. He's a failure.

He keeps creating new companies after he's bleed dry the other companies.

Look at the so called business plan. He's not stuck to it one bit. It's a unworkable business plan. It's a failure just like Koos is.

Regen is like buying a lotto ticket. You think you have a chance but in reality, you are just throwing your money away.

Nice volume and almost all buys today but no significant move in price. No idea who hold it down and why.

Ha oK ! so a thousand apologies and I hope that during a rally you can get your money back !